[1]
|
Sosso, F.A.E. and Kabore, P. (2016) The African Burden of Mental Health. Journal of Mental Disorders and Treatment, 2, 1222.
https://doi.org/10.4172/2471-271X.1000122
|
[2]
|
Liberski, P.P. (2013) Kuru: A Papua New Guinea to the Neanderthals’ Extinction. Pathogens, 2, 472-505. https://doi.org/10.3390/pathogens2030472
|
[3]
|
NPR.org. (2017) When People Ate People, a Strange Disease Emerged.
https://www.npr.org/sections/thesalt/2016/09/06/482952588/when-people-ate-people-a-strange-disease-emerged
|
[4]
|
Almond, J.W. (1998) Bovine Spongiform Encephalopathy and New Variant Creutzfeldt-Jakob Disease. British Medical Bulletin, 54, 749-759.
https://doi.org/10.1093/oxfordjournals.bmb.a011724
|
[5]
|
Collinge, J., et al. (1994) Prion Protein Is Necessary for Normal Synaptic Function. Nature, 370, 295-297. https://doi.org/10.1038/370295a0
|
[6]
|
Dormont, D. (2002) Prion Diseases: Pathogenesis and Public Health Concerns. FEBS Letters, 529, 17-21. https://doi.org/10.1016/S0014-5793(02)03268-4
|
[7]
|
Choi, D.K., Kim, I.S. and Do, J.H. (2014) Signaling Pathway Analysis of MPP+-Treated Human Neuroblastoma SH-SY5Y Cells. Biotechnology and Bioprocess Engineering, 19, 332-340. https://doi.org/10.1007/s12257-013-0754-x
|
[8]
|
La Mendola, D., et al. (2008) Prion Proteins Leading to Neurodegeneration. Current Alzheimer Research, 5, 579-590. https://doi.org/10.2174/156720508786898415
|
[9]
|
Martins, V.R., et al. (2001) Insights into the Physiological Function of Cellular Prion Protein. Brazilian Journal of Medical and Biological Research, 34, 585-595.
https://doi.org/10.1590/S0100-879X2001000500005
|
[10]
|
Lee, K.J., et al. (2007) Cellular Prion Protein (PrPC) Protects Neuronal Cells from the Effect of Huntingtin Aggregation. Journal of Cell Science, 120, 2663-2671.
https://doi.org/10.1242/jcs.004598
|
[11]
|
Westergard, L., Christensen, H.M. and Harris, D.A. (2007) The Cellular Prion Protein (PrPC): Its Physiological Function and Role in Disease. Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, 1772, 629-644.
https://doi.org/10.1016/j.bbadis.2007.02.011
|
[12]
|
Solomon, I.H., Schepker, J.A. and Harris, D.A. (2010) Prion Neurotoxicity: Insights from Prion Protein Mutants. Current Issues in Molecular Biology, 12, 51-61.
|
[13]
|
Castle, A.R. and Gill, A.C. (2017) Physiological Functions of the Cellular Prion Protein. Frontiers in Molecular Biosciences, 4, 19.
https://doi.org/10.3389/fmolb.2017.00019
|
[14]
|
Kozlowski, H., et al. (2009) Copper, Iron, and Zinc Ions Homeostasis and Their Role in Neurodegenerative Disorders (Metal Uptake, Transport, Distribution and Regulation). Coordination Chemistry Reviews, 253, 2665-2685.
https://doi.org/10.1016/j.ccr.2009.05.011
|
[15]
|
Onodera, T. (2017) Dual Role of Cellular Prion Protein in Normal Host and Alzheimer’s Disease. Proceedings of the Japan Academy. Series B, Physical and Biological Sciences, 93, 155-173. https://doi.org/10.2183/pjab.93.010
|
[16]
|
McKinley, M.P., et al. (1987) Developmental Expression of Prion Protein Gene in Brain. Developmental Biology, 121, 105-110.
https://doi.org/10.1016/0012-1606(87)90143-6
|
[17]
|
Ciric, D. and Rezaei, H. (2015) Biochemical Insight into the Prion Protein Family. Frontiers in Cell and Developmental Biology, 3, 5.
https://doi.org/10.3389/fcell.2015.00005
|
[18]
|
Harris, D.A. (1999) Cellular Biology of Prion Diseases. Clinical Microbiology Reviews, 12, 429-444. https://doi.org/10.1128/CMR.12.3.429
|
[19]
|
Otvos, L. and Cudic, M. (2002) Post-Translational Modifications in Prion Proteins. Current Protein & Peptide Science, 3, 643-652.
https://doi.org/10.2174/1389203023380440
|
[20]
|
Duan, G. and Walther, D. (2015) The Roles of Post-Translational Modifications in the Context of Protein Interaction Networks. PLoS Computational Biology, 11, e1004049. https://doi.org/10.1371/journal.pcbi.1004049
|
[21]
|
Tessier, P.M. and Lindquist, S. (2009) Unraveling Infectious Structures, Strain Variants and Species Barriers for the Yeast Prion [PSI+]. Nature Structural & Molecular Biology, 16, 598-605. https://doi.org/10.1038/nsmb.1617
|
[22]
|
Woodsmith, J., Kamburov A. and Stelzl, U. (2013) Dual Coordination of Post Translational Modifications in Human Protein Networks. PLoS Computational Biology, 9, e1002933. https://doi.org/10.1371/journal.pcbi.1002933
|
[23]
|
Holman, R.C., et al. (2010) Human Prion Diseases in the United States. PLoS ONE, 5, e8521. https://doi.org/10.1371/journal.pone.0008521
|
[24]
|
Grizel, A.V., Rubel, A.A. and Chernoff, Y.O. (2016) Strain Conformation Controls the Specificity of Cross-Species Prion Transmission in the Yeast Model. Prion, 10, 269-282. https://doi.org/10.1080/19336896.2016.1204060
|
[25]
|
Cobb, N.J. and Surewicz, W.K. (2009) Prion Diseases and Their Biochemical Mechanisms. Biochemistry, 48, 2574-2585. https://doi.org/10.1021/bi900108v
|
[26]
|
Marin-Moreno, A., et al. (2017) Transmission and Replication of Prions. Progress in Molecular Biology and Translational Science, 150, 181-201.
https://doi.org/10.1016/bs.pmbts.2017.06.014
|
[27]
|
Gambetti, P., et al. (2003) Sporadic and Familial CJD: Classification and Characterisation. British Medical Bulletin, 66, 213-239.
https://doi.org/10.1093/bmb/66.1.213
|
[28]
|
Morales, R. (2017) Prion Strains in Mammals: Different Conformations Leading to Disease. PLoS Pathogens, 13, e1006323.
https://doi.org/10.1371/journal.ppat.1006323
|
[29]
|
Wadsworth, J.D.F., Kong, Q., Zou, W., Parchi, P. and Chen, S.G. (2003) Molecular and Clinical Classification of Human Prion Disease. British Medical Bulletin, 66, 241-254. https://doi.org/10.1093/bmb/66.1.241
|
[30]
|
Chen, C. and Dong, X.P. (2016) Epidemiological Characteristics of Human Prion Diseases. Infectious Diseases of Poverty, 5, 47.
https://doi.org/10.1186/s40249-016-0143-8
|
[31]
|
Reiniger, L., et al. (2013) Filamentous White Matter Prion Protein Deposition Is a Distinctive Feature of Multiple Inherited Prion Diseases. Acta Neuropathologica Communications, 1, 8. https://doi.org/10.1186/2051-5960-1-8
|
[32]
|
Takada, L.T. and Geschwind, M.D. (2013) Prion Diseases. Seminars in Neurology, 33, 348-356. https://doi.org/10.1055/s-0033-1359314
|
[33]
|
Rodriguez, M.M., et al. (2005) A Novel Mutation (G114V) in the Prion Protein Gene in a Family with Inherited Prion Disease. Neurology, 64, 1455-1477.
https://doi.org/10.1212/01.WNL.0000158618.39527.93
|
[34]
|
Nakatani, E. (2016) Specific Clinical Signs and Symptoms Are Predictive of Clinical Course in Sporadic Creutzfeldt-Jakob Disease. European Journal of Neurology, 23, 1455-1462. https://doi.org/10.1111/ene.13057
|
[35]
|
Wijesekera, L.C. and Leigh, P.N. (2009) Amyotrophic Lateral Sclerosis. Orphanet Journal of Rare Diseases, 4, 3. https://doi.org/10.1186/1750-1172-4-3
|
[36]
|
Desai, M.S.J. (2000) Motor Neuron Disease: Classification and Nomenclature. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 1, 105-112.
https://doi.org/10.1080/14660820050515403
|
[37]
|
Statland, J.M., et al. (2015) Patterns of Weakness, Classification of Motor Neuron Disease & Clinical Diagnosis of Sporadic ALS. Neurologic Clinics, 33, 735-748.
https://doi.org/10.1016/j.ncl.2015.07.006
|
[38]
|
Chen, S., Barohn, R.J., McVey, A.L., Katz, J.S. and Dimachkie, M.M. (2013) Genetics of Amyotrophic Lateral Sclerosis: An Update. Molecular Neurodegeneration, 8, 28. https://doi.org/10.1186/1750-1326-8-28
|
[39]
|
Parakh, S. and Atkin, J.D. (2016) Protein Folding Alterations in Amyotrophic Lateral Sclerosis. Brain Research, 1648, 633-649.
https://doi.org/10.1016/j.brainres.2016.04.010
|
[40]
|
Renton, A.E., et al. (2011) A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD. Neuron, 72, 257-268.
https://doi.org/10.1016/j.neuron.2011.09.010
|
[41]
|
Van Blitterswijk, M., DeJesus-Hernandez, M. and Rademakers, R. (2012) How Do C9ORF72 Repeat Expansions Cause ALS and FTD: Can We Learn from Other Non-Coding Repeat Expansion Disorders? Current Opinion in Neurology, 25, 689-700. https://doi.org/10.1097/WCO.0b013e32835a3efb
|
[42]
|
Shaw, R. (2005) Molecular and Cellular Pathways of Neurodegeneration in Motor Neurone Disease. Journal of Neurology, Neurosurgery, and Psychiatry, 76, 1046-1057. https://doi.org/10.1136/jnnp.2004.048652
|
[43]
|
Foran, E. and Trotti, D. (2009) Glutamate Transporters and the Excitotoxic Path to Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis. Antioxidants & Redox Signaling, 11, 1587-1602. https://doi.org/10.1089/ars.2009.2444
|
[44]
|
Zarei, S., et al. (2015) A Comprehensive Review of Amyotrophic Lateral Sclerosis. Surgical Neurology International, 6, 171. https://doi.org/10.4103/2152-7806.169561
|
[45]
|
Roos, P., Vesterberg, O. and Nordberg, M. (2006) Metals in Motor Neuron Diseases. Experimental Biology and Medicine, 231, 1481-1487.
https://doi.org/10.1177/153537020623100906
|
[46]
|
Chen, X., Guo, C. and Kong, J. (2012) Oxidative Stress in Neurodegenerative Diseases. Neural Regeneration Research, 7, 376-385.
|
[47]
|
Akhtar, R. (2004) Bcl-2 Family Regulation of Neuronal Development and Neurodegeneration. Biochimica et Biophysica Acta, 1644, 189-203.
https://doi.org/10.1016/j.bbamcr.2003.10.013
|
[48]
|
Hetz, C., et al. (2007) The Proapoptotic BCL-2 Family Member BIM Mediates Motoneuron Loss in a Model of Amyotrophic Lateral Sclerosis. Cell Death and Differentiation, 14, 1386-1389. https://doi.org/10.1038/sj.cdd.4402166
|
[49]
|
Ramesh, N. and Pandey, U.B. (2017) Autophagy Dysregulation in ALS: When Protein Aggregates Get Out of Hand. Frontiers in Molecular Neuroscience, 10, 263.
https://doi.org/10.3389/fnmol.2017.00263
|
[50]
|
Cheon, C.K., et al. (2017) Autosomal Dominant Transmission of Complicated Hereditary Spastic Paraplegia Due to a Dominant Negative Mutation of KIF1A, SPG30 Gene. Scientific Reports, 7, Article No. 12527.
https://doi.org/10.1038/s41598-017-12999-9
|
[51]
|
Ninds.nih.gov (2017) Motor Neuron Diseases Fact Sheet. National Institute of Neurological Disorders and Stroke.
https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Motor-Neuron-Diseases-Fact-Sheet
|
[52]
|
Burghes, A.H.M. and Beattie, C.E. (2009) Spinal Muscular Atrophy: Why Do Low Levels of Survival Motor Neuron Protein Make Motor Neurons Sick? Nature Reviews Neuroscience, 10, 597-609. https://doi.org/10.1038/nrn2670
|
[53]
|
Sharma, K.R., Saigal, G., Maudsley, A.A. and Govind, V. (2011) 1H MRS of Basal Ganglia and Thalamus in Amyotrophic Lateral Sclerosis. NMR in Biomedicine, 24, 1270-1276. https://doi.org/10.1002/nbm.1687
|
[54]
|
Bede, P., et al. (2013) Basal Ganglia Involvement in Amyotrophic Lateral Sclerosis. Neurology, 81, 2107-2115. https://doi.org/10.1212/01.wnl.0000437313.80913.2c
|
[55]
|
Vargas, M.R. and Johnson, J.A. (2010) Astrogliosis in Amyotrophic Lateral Sclerosis: Role and Therapeutic Potential of Astrocytes. Neurotherapeutics, 7, 471-481.
https://doi.org/10.1016/j.nurt.2010.05.012
|
[56]
|
Frakes, A.E., et al. (2014) Microglia Induce Motor Neuron Death via the Classical NF-κB Pathway in Amyotrophic Lateral Sclerosis. Neuron, 81, 1009-1023.
https://doi.org/10.1016/j.neuron.2014.01.013
|
[57]
|
Polvikoski, T.M., Murray, A., Harper, P. and Neal, J. (2003) Familial Motor Neurone Disease with Dementia: Phenotypic Variation and Cerebellar Pathology. Journal of Neurology, Neurosurgery & Psychiatry, 74, 1516-1520.
https://doi.org/10.1136/jnnp.74.11.1516
|
[58]
|
Leighton, S.E., Burton, M.J., Lund, W.S. and Cochrane, G.M. (1994) Swallowing in Motor Neurone Disease. Journal of the Royal Society of Medicine, 87, 801-805.
|
[59]
|
Watts, C.R. and Vanryckeghem, M. (2001) Laryngeal Dysfunction in Amyotrophic Lateral Sclerosis: A Review and Case Report. BMC Ear, Nose and Throat Disorders, 1, 1. https://doi.org/10.1186/1472-6815-1-1
|
[60]
|
Atassi, N., et al. (2011) Depression in Amyotrophic Lateral Sclerosis. Amyotrophic Lateral Sclerosis, 12, 109-112. https://doi.org/10.3109/17482968.2010.536839
|
[61]
|
Chiesa, R. and Harris, D.A. (2009) Fishing for Prion Protein Function. PLoS Biology, 7, e1000075. https://doi.org/10.1371/journal.pbio.1000075
|
[62]
|
Lee, Y.J. and Baskakov, I.V. (2014) The Cellular Form of the Prion Protein Guides the Differentiation of Human Embryonic Stem Cells into Neuron-, Oligodendrocyte-, and Astrocyte-Committed Lineages. Prion, 8, 266-275.
https://doi.org/10.4161/pri.32079
|
[63]
|
Shi, F., et al. (2016) Cellular Prion Protein Promotes Neuronal Differentiation of Adipose-Derived Stem Cells by Upregulating miRNA-124. Journal of Molecular Neuroscience, 59, 48-55. https://doi.org/10.1007/s12031-016-0733-8
|
[64]
|
Mouillet-Richard, S., et al. (2000) Signal Transduction through Prion Protein. Science, 289, 1925-1928. https://doi.org/10.1126/science.289.5486.1925
|
[65]
|
Resenberge, U.K., Winklhofer, K.F. and Tatzelt, J. (2011) Neuroprotective and Neurotoxic Signaling by the Prion Protein. Topics in Current Chemistry, 305, 101-119. https://doi.org/10.1007/128_2011_160
|
[66]
|
Liebert, A., Bicknell, B. and Adams, R. (2014) Prion Protein Signaling in the Nervous System—A Review and Perspective. Signal Transduction Insights, 3, 11-32.
https://doi.org/10.4137/STI.S12319
|
[67]
|
Maciejewski, A., et al. (2016) Domains of STIP1 Responsible for Regulating the PrPC-Dependent Amyloid-β Oligomer Toxicity. Biochemical Journal, 473, 2119-2130. https://doi.org/10.1042/BCJ20160087
|
[68]
|
Xu, F., Karnaukhova, E. and Vostal, J.G. (2008) Human Cellular Prion Protein Interacts Directly with Clusterin Protein. Biochimica et Biophysica Acta, 1782, 615-620. https://doi.org/10.1016/j.bbadis.2008.08.004
|
[69]
|
Cai, Y., et al. (2016) Interplay of Endoplasmic Reticulum Stress and Autophagy in Neurodegenerative Disorders. Autophagy, 12, 225-244.
https://doi.org/10.1080/15548627.2015.1121360
|
[70]
|
Gibbings, D., et al. (2012) Human Prion Protein Binds Argonaute and Promotes Accumulation of microRNA Effector Complexes. Nature Structural & Molecular Biology, 19, 517-524. https://doi.org/10.1038/nsmb.2273
|
[71]
|
David, R. (2011) BAG6 & Mislocalized Proteins. Nature Reviews Molecular Cell Biology, 12, 550. https://doi.org/10.1038/nrm3167
|
[72]
|
Das, J. and Yu, H. (2012) HINT: High-Quality Protein Interactomes and Their Applications in Understanding Human Disease. BMC Systems Biology, 6, 92.
https://doi.org/10.1186/1752-0509-6-92
|
[73]
|
Szklarczyk, D., et al. (2015) STRING v10: Protein–Protein Interaction Networks, Integrated over the Tree of Life. Nucleic Acids Research, 43, D447-D452.
https://doi.org/10.1093/nar/gku1003
|
[74]
|
Stark, C., et al. (2006) BioGRID: A General Repository for Interaction Datasets. Nucleic Acids Research, 34, D535-D539. https://doi.org/10.1093/nar/gkj109
|
[75]
|
Keshava Prasad, T.S., et al. (2009) Human Protein Reference Database—2009 Update. Nucleic Acids Research, 37, D767-D772.
https://doi.org/10.1093/nar/gkn892
|
[76]
|
Chatr-aryamontri, A., et al. (2007) MINT: The Molecular INTeraction Database. Nucleic Acids Research, 35, D572-D574. https://doi.org/10.1093/nar/gkl950
|
[77]
|
Peri, S., et al. (2003) Development of Human Protein Reference Database as an Initial Platform for Approaching Systems Biology in Humans. Genome Research, 13, 2363-2371. https://doi.org/10.1101/gr.1680803
|
[78]
|
Warde-Farley, D., et al. (2010) The GeneMANIA Prediction Server: Biological Network Integration for Gene Prioritization and Predicting Gene Function. Nucleic Acids Research, 38, W214-W220. https://doi.org/10.1093/nar/gkq537
|
[79]
|
Rolland, T., et al. (2014) A Proteome-Scale Map of the Human Interactome Network. Cell, 159, 1212-1226. https://doi.org/10.1016/j.cell.2014.10.050
|
[80]
|
Kurschner, C. and Morgan, J.I. (1995) The Cellular Prion Protein (PrP) Selectively Binds to Bcl-2 in the Yeast Two-Hybrid System. Molecular Brain Research, 30, 165-168. https://doi.org/10.1016/0169-328X(95)00013-I
|
[81]
|
Ferreiro, E., et al. (2007) Bcl-2 Overexpression Protects Against Amyloid-Beta and Prion Toxicity in GT1-7 Neural Cells. Journal of Alzheimer’s Disease, 12, 223-228.
https://doi.org/10.3233/JAD-2007-12303
|
[82]
|
Kralovicova, S., et al. (2009) The Effects of Prion Protein Expression on Metal Metabolism. Molecular and Cellular Neuroscience, 41, 135-147.
https://doi.org/10.1016/j.mcn.2009.02.002
|
[83]
|
Kaiser, D.M., et al. (2012) Amyloid Beta Precursor Protein and Prion Protein Have a Conserved Interaction Affecting Cell Adhesion and CNS Development. PLoS ONE, 7, e51305. https://doi.org/10.1371/journal.pone.0051305
|
[84]
|
McHugh, P.C., et al. (2012) Prion Protein Expression Alters APP Cleavage without Interaction with BACE-1. Neurochemistry International, 61, 672-680.
https://doi.org/10.1016/j.neuint.2012.07.002
|
[85]
|
Bai, Y., et al. (2008) The in Vivo Brain Interactome of the Amyloid Precursor Protein. Molecular & Cellular Proteomics, 7, 15-34.
https://doi.org/10.1074/mcp.M700077-MCP200
|
[86]
|
Satoh, J., et al. (2008) Protein Microarray Analysis Identifies Human Cellular Prion Protein Interactors. Neuropathology and Applied Neurobiology, 35, 16-35.
https://doi.org/10.1111/j.1365-2990.2008.00947.x
|
[87]
|
Klamt, F., et al. (2001) Imbalance of Antioxidant Defense in Mice Lacking Cellular Prion Protein. Free Radical Biology & Medicine, 30, 1137-1144.
https://doi.org/10.1016/S0891-5849(01)00512-3
|
[88]
|
Spee, B., et al. (2006) Copper Metabolism and Oxidative Stress in Chronic Inflammatory and Cholestatic Liver Diseases in Dogs. Journal of Veterinary Internal Medicine, 20, 1085-1092. https://doi.org/10.1111/j.1939-1676.2006.tb00706.x
|
[89]
|
Stetler, R.A., et al. (2010) Heat Shock Proteins: Cellular and Molecular Mechanisms in the CNS. Progress in Neurobiology, 92, 184-211.
https://doi.org/10.1016/j.pneurobio.2010.05.002
|
[90]
|
Kelly, P.N. and Strasser, A. (2011) The Role of Bcl-2 and Its Pro-Survival Relatives in Tumourigenesis and Cancer Therapy. Cell Death and Differentiation, 18, 1414-1424. https://doi.org/10.1038/cdd.2011.17
|
[91]
|
Brown, D.R. and Besinger, A. (1998) Prion Protein Expression and Superoxide Dismutase Activity. Biochemical Journal, 334, 423-429.
https://doi.org/10.1042/bj3340423
|
[92]
|
Hutter, G., Heppner, F.L. and Aguzzi, A. (2003) No Superoxide Dismutase Activity of Cellular Prion Protein in Vivo. Biological Chemistry, 384, 1279-1285.
https://doi.org/10.1515/BC.2003.142
|
[93]
|
Jones, S., et al. (2005) Recombinant Prion Protein Does Not Possess SOD-1 Activity. Biochemical Journal, 392, 309-312. https://doi.org/10.1042/BJ20051236
|
[94]
|
Choi, C.J., et al. (2006) Interaction of Metals with Prion Protein: Possible Role of Divalent Cations in the Pathogenesis of Prion Diseases. Neurotoxicology, 27, 777-787. https://doi.org/10.1016/j.neuro.2006.06.004
|
[95]
|
Toni, M., Massimino, M.L., Griffoni, C., Salvato, B., Tomasi, V. and Spisni, E. (2005) Extracellular Copper Ions Regulate Cellular Prion Protein (PrPC) Expression and Metabolism in Neuronal Cells. FEBS Letters, 579, 741-744.
https://doi.org/10.1016/j.febslet.2004.12.053
|
[96]
|
Peggion, C., Bertoli, A. and Sorgato, M.C. (2017) Almost a Century of Prion Protein(s): From Pathology to Physiology, and Back to Pathology. Biochemical and Biophysical Research Communications, 483, 1148-1155.
https://doi.org/10.1016/j.bbrc.2016.07.118
|
[97]
|
Herms, J.W., Tings, T., Dunker, S. and Kretzschmar, H.A. (2001) Prion Protein Affects Ca2+-Activated K+ Currents in Cerebellar Purkinje Cells. Neurobiology of Disease, 8, 324-330. https://doi.org/10.1006/nbdi.2000.0369
|
[98]
|
Korte, S., et al. (2003) Modulation of L-Type Voltage-Gated Calcium Channels by Recombinant Prion Protein. Journal of Neurochemistry, 87, 1037-1042.
https://doi.org/10.1046/j.1471-4159.2003.02080.x
|
[99]
|
Choi, D.K., Su Kim, I. and Do, J.H. (2014) Signaling Pathway Analysis of MPP+-Treated Human Neuroblastoma SH-SY5Y Cells. Biotechnology and Bioprocess Engineering, 19, 332-340. https://doi.org/10.1007/s12257-013-0754-x
|
[100]
|
Macario, A.J. and Conway de Macario, E. (2005) Sick Chaperones, Cellular Stress, and Disease. New England Journal of Medicine, 353, 1489-1501.
https://doi.org/10.1056/NEJMra050111
|
[101]
|
Goold, R., McKinnon, C. and Tabrizi, S.J. (2015) Prion Degradation Pathways: Potential for Therapeutic Intervention. Molecular and Cellular Neurosciences, 66, 12-20. https://doi.org/10.1016/j.mcn.2014.12.009
|
[102]
|
Hishiya, A. and Takayama, S. (2008) Molecular Chaperones as Regulators of Cell Death. Oncogene, 27, 6489-6506. https://doi.org/10.1038/onc.2008.314
|
[103]
|
Proescher, J.B., Son, M., Elliott, J.L. and Culotta, V.C. (2008) Biological Effects of CCS in the Absence of SOD1 Enzyme Activation: Implications for Disease in a Mouse Model for ALS. Human Molecular Genetics, 17, 1728-1737.
https://doi.org/10.1093/hmg/ddn063
|
[104]
|
Aguzzi, A. and Calella, A.M. (2009) Prions: Protein Aggregation and Infectious Diseases. Physiological Reviews, 89, 1105-1152.
https://doi.org/10.1152/physrev.00006.2009
|
[105]
|
Brown, D.R. (2004) Role of the Prion Protein in Copper Turnover in Astrocytes. Neurobiology of Disease, 15, 534-543. https://doi.org/10.1016/j.nbd.2003.11.009
|
[106]
|
Desai, V. and Kaler, S.G. (2008) Role of Copper in Human Neurological Disorders. American Journal of Clinical Nutrition, 88, 855s-858s.
https://doi.org/10.1093/ajcn/88.3.855S
|
[107]
|
Deriziotis, B. and Tabrizi, S.J. (2008) Prions and the Proteasome. Biochimica et Biophysica Acta, 1782, 713-722. https://doi.org/10.1016/j.bbadis.2008.06.011
|
[108]
|
Yano, M., Koumoto, Y., Kanesaki, Y., Wu, X. and Kido, H. (2004) 20S Proteasome Prevents Aggregation of Heat-Denatured Proteins without PA700 Regulatory Subcomplex like a Molecular Chaperone. Biomacromolecules, 5, 1465-1469.
https://doi.org/10.1021/bm049957a
|
[109]
|
Rowland, L.P. and Shneider, N.A. (2001) Amyotrophic Lateral Sclerosis. New England Journal of Medicine, 344, 1688-1700.
https://doi.org/10.1056/NEJM200105313442207
|
[110]
|
Steele, A.D., Lindquist, S. and Aguzzi, A. (2007) The Prion Protein Knockout Mouse: A Phenotype under Challenge. Prion, 1, 83-93.
https://doi.org/10.4161/pri.1.2.4346
|
[111]
|
Winklhofer, K.F., Tatzelt, J. and Haass, C. (2008) The Two Faces of Protein Misfolding: Gain- and Loss-of-Function in Neurodegenerative Diseases. The EMBO Journal, 27, 336-349. https://doi.org/10.1038/sj.emboj.7601930
|
[112]
|
Saccon, R.A., Bunton-Stasyshyn, R.K.A., Fisher, E.M.C. and Fratta, P. (2013) Is SOD1 Loss of Function Involved in Amyotrophic Lateral Sclerosis? Brain, 136, 2342-2358. https://doi.org/10.1093/brain/awt097
|
[113]
|
Li, J., Wuliji, O., Li, W., Jiang, Z.G. and Ghanbari, H.A. (2013) Oxidative Stress and Neurodegenerative Disorders. International Journal of Molecular Sciences, 14, 24438-24475. https://doi.org/10.3390/ijms141224438
|
[114]
|
Onodera, T., Sakudo, A., Tsubone, H. and Itohara, S. (2014) Review of Studies That Have Used Knockout Mice to Assess Normal Function of Prion Protein under Immunological or Pathophysiological Stress. Microbiology and Immunology, 58, 361-374. https://doi.org/10.1111/1348-0421.12162
|
[115]
|
Freixes, M., et al. (2004) Clusterin Solubility and Aggregation in Creutzfeldt-Jakob Disease. Acta Neuropathologica, 108, 295-301.
https://doi.org/10.1007/s00401-004-0891-6
|
[116]
|
Ciechanover, A. and Kwon, Y.T. (2015) Degradation of Misfolded Proteins in Neurodegenerative Diseases: Therapeutic Targets and Strategies. Experimental and Molecular Medicine, 47, e147. https://doi.org/10.1038/emm.2014.117
|
[117]
|
Hall, T.M. (2005) Structure and Function of Argonaute Proteins. Structure, 13, 1403-1408. https://doi.org/10.1016/j.str.2005.08.005
|
[118]
|
Wilczynska, A. and Bushell, M. (2015) The Complexity of miRNA-Mediated Repression. Cell Death and Differentiation, 22, 22-33.
https://doi.org/10.1038/cdd.2014.112
|
[119]
|
Gibbings, D., et al. (2012) Human Prion Protein Binds Argonaute and Promotes Accumulation of microRNA Effector Complexes. Nature Structural & Molecular Biology, 19, 517-524. https://doi.org/10.1038/nsmb.2273
|